Inventionmed (WAR:INM) Beneish M-Score: 5.78 (As of Jun. 25, 2026) — 145% Above Median


WAR:INM Inventionmed SA WAR:INM
17 GF Score
Price zł0.11
! 7 Warning Signs
View Full Analysis

What is Inventionmed Beneish M-Score?

Inventionmed WAR:INM 17 Beneish M-Score is 5.78 as of Jun. 25, 2026, which is 145% above its 10-year median of 2.36. GuruFocus rates WAR:INM with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 765 Medical Devices & Instruments companies, Inventionmed ranks worse than 97.91% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 5.78 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Inventionmed's Beneish M-Score or its related term are showing as below:

WAR:INM' s Beneish M-Score Range Over the Past 10 Years
Min: -10.5   Med: 2.36   Max: 157.18
Current: 5.78

During the past 13 years, the highest Beneish M-Score of Inventionmed was 157.18. The lowest was -10.50. And the median was 2.36.


Inventionmed Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Inventionmed's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventionmed Beneish M-Score Chart

Inventionmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.50 48.40 0.00 0.00 5.78

Inventionmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 5.78 0.00

WAR:INM vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Inventionmed's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventionmed Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inventionmed's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Inventionmed's Beneish M-Score falls into.


WAR:INM
17GF Score
Inventionmed SA WAR:INM
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inventionmed Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Inventionmed for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.3148+0.528 * 0.3839+0.404 * 0.9525+0.892 * 11.4065+0.115 * 0.9492
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.006352-0.327 * 1.0353
=5.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was zł2.66 Mil.
Revenue was zł3.17 Mil.
Gross Profit was zł2.91 Mil.
Total Current Assets was zł2.77 Mil.
Total Assets was zł39.51 Mil.
Property, Plant and Equipment(Net PPE) was zł27.54 Mil.
Depreciation, Depletion and Amortization(DDA) was zł0.89 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.00 Mil.
Total Current Liabilities was zł0.95 Mil.
Long-Term Debt & Capital Lease Obligation was zł2.68 Mil.
Net Income was zł-0.75 Mil.
Gross Profit was zł0.00 Mil.
Cash Flow from Operations was zł-0.50 Mil.
Total Receivables was zł0.74 Mil.
Revenue was zł0.28 Mil.
Gross Profit was zł0.10 Mil.
Total Current Assets was zł0.84 Mil.
Total Assets was zł37.89 Mil.
Property, Plant and Equipment(Net PPE) was zł27.78 Mil.
Depreciation, Depletion and Amortization(DDA) was zł0.85 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.00 Mil.
Total Current Liabilities was zł0.87 Mil.
Long-Term Debt & Capital Lease Obligation was zł2.49 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2.657 / 3.171) / (0.74 / 0.278)
=0.837906 / 2.661871
=0.3148

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.098 / 0.278) / (2.912 / 3.171)
=0.352518 / 0.918322
=0.3839

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2.772 + 27.537) / 39.513) / (1 - (0.842 + 27.781) / 37.889)
=0.232936 / 0.244556
=0.9525

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3.171 / 0.278
=11.4065

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.849 / (0.849 + 27.781)) / (0.888 / (0.888 + 27.537))
=0.029654 / 0.03124
=0.9492

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 3.171) / (0 / 0.278)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.678 + 0.953) / 39.513) / ((2.491 + 0.872) / 37.889)
=0.091894 / 0.088759
=1.0353

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-0.749 - 0 - -0.498) / 39.513
=-0.006352

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Inventionmed has a M-score of 5.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 5.78 mean?
Inventionmed (WAR:INM) has a Beneish M-Score of 5.78 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Inventionmed and its competitors. This is 145% above median its historical median of 2.36. According to the industry distribution chart, Inventionmed ranks #749 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 97.9%.
Is Inventionmed's Beneish M-Score too high?
Inventionmed's current Beneish M-Score of 5.78 is 145% above median its 10-year median of 2.36. Based on the distribution chart, Inventionmed ranks #749 out of 765 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Inventionmed has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Inventionmed's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Inventionmed ranks #749 out of 765 companies for Beneish M-Score. This places Inventionmed in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Inventionmed and its competitors. Inventionmed's current Beneish M-Score is 5.78, which is 145% above median its own 10-year median of 2.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inventionmed stock overvalued right now?
Inventionmed (WAR:INM) has a current Beneish M-Score of 5.78. The current Beneish M-Score is 5.78, which is 145% above median its 10-year median of 2.36. Inventionmed's overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Inventionmed (WAR:INM), the current Beneish M-Score is 5.78 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inventionmed Business Description

Address Jana Zamoyskiego 2B Street, Bydgoszcz, POL, 85-063
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The company's project consists of TutorDerm, Double immersion, Virtual Syringe, and others.
17GF Score

Get the complete analysis for WAR:INM

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.11
Price